BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2004
View Archived Issues
Naturally occurring spirostenol prevents beta-amyloid-induced toxicity
Read More
Identification of active metabolites of selective COX-2 inhibitor
Read More
Behavioral improvements associated with sertraline in Alzheimer's disease
Read More
Improved glycemic control achieved with repaglinide plus pioglitazone in type 2 diabetes
Read More
Clavulanate improves the efficacy of standard therapy for H. pylori infection
Read More
Although ineffective alone, NAC in combination with deferoxamine is protective in a rat sepsis model
Read More
AnGes files IND for phase I trials of HGF
Read More
Technology transfer completed in Actelion/Merck renin alliance
Read More
Ultrafine completes scale-up of PPA-605 and PPA-904
Read More
Abbott and Corixa in agreement for Chagas' disease blood screening technology
Read More
Preliminary findings from Women's Health Initiative and memory substudy
Read More
Yakult Honsha files Japanese import application for oxaliplatin
Read More
Transgene highlights 2003 developments
Read More
Avigen continues to move forward with product development portfolio
Read More
Lilly claims new SERMs for endometriosis and uterine leiomyoma therapy
Read More
Novel NO-releasing prodrugs of COX-2 inhibitors and their use
Read More
Two novel series of chemokine CCR1 antagonists identified at Pfizer
Read More
NeuroSearch team prepares and tests new opioid receptor ligands
Read More
Guanylate cyclase as a target for the treatment of cognitive disorders
Read More
Novel iNOS inhibitors for IBD, arthritis and pain designed at AstraZeneca
Read More
Micrologix presents nucleoside-based anti-HBV agents
Read More
NIH licensing technology for improved process to produce the steroid CDB-2914
Read More
SR-4554 available for licensing from Cancer Research Technology
Read More
Canadian approval for one- and three-month Eligard products
Read More
New phase II trial for insulin sensitizer MBX-102
Read More
Phase I trials for DRF-10945 commence in Canada
Read More
German approval for Gamunex
Read More
Japanese approval for Serevent 50 Diskus
Read More
Aldara approved for actinic keratoses
Read More
Altastaph receives fast track designation
Read More
Hemispherx Biopharma cleared to commence phase II Alferon LDO study
Read More